Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil can help grow hair and make hair follicles bigger, but it can also cause side effects.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Ammonium bisulfite in hair bleach can cause facial eczema.

Hair product allergies are common, especially to hair dyes, and hairdressers are at higher risk.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Antidepressants called SSRIs can cause skin problems, bleeding risk, and other side effects.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Propranolol combined with injections caused skin changes in guinea pigs but didn't fully mimic psoriasis.

Minoxidil can cause deadly skin reaction; monitor patients closely.

The document concludes that a complete skin restoration biomaterial does not yet exist, and more clinical trials are needed to ensure these therapies are safe and effective.

The document discusses how to identify and manage common skin conditions in children.

Superficial granulomatous pyoderma is a unique, mild form of skin disease that often heals without strong medication and responds well to milder treatments.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

HIV patients with lower CD4 T cell counts often have more skin problems.

Educators who survived COVID-19 faced physical, psychological, and social challenges but overcame them with resilience and support, highlighting the need for schools to provide better health and psychological care.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

St. John's Wort extract and oil safety in cosmetics is unclear; more data needed on photosensitization, toxicity, and human irritation.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

The document concludes that various skin conditions have specific characteristics and treatments, and highlights the importance of vitamin D in managing these dermatological issues.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

The document concludes that various hypersensitivity diseases in horses can be diagnosed and treated with methods like immunotherapy and medication, and early aggressive treatment is crucial for severe diseases like equine cutaneous pythiosis.

Netherton's syndrome is linked to high IgE levels and unique skin and hair symptoms, and may improve with ammonium lactate lotion and allergy management.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.